I turned 80 in June, and my father died of prostate cancer at the age of 81, so I have more than a casual interest in the subject. Of course, when he died 29 years ago, we did not know what we know now, because the federal government has done everything possible to block research on marijuana.
According to a study published by the U.S. National Institutes for Health:
“Prostate cancer is the most common cancer in men (aside from non-melanoma skin cancer) and the second most common cause of cancer death in the United States. Even with widespread screening with prostate-specific antigen (PSA), still 5% of cases present with metastatic lesions at the time of diagnosis. Because of all this, there is a fundamental necessity to search for and find new and novel treatments to this common pathology. Cannabis and cannabinoids have often been an issue of much polemics in the realm of science, but since the discovery of cannabinoid receptors in rat brain in the late 1980s, there has been a growing interest in the research of these compounds and our knowledge continues to expand. There has been experimental evidence that cannabinoids possess anti-androgenic proprieties.”
Read full here: